McKesson Co. (NYSE:MCK) Shares Purchased by Dorsey Wright & Associates
McKesson Co. (NYSE:MCK) Shares Purchased by Dorsey Wright & Associates
Dorsey Wright & Associates raised its position in shares of McKesson Co. (NYSE:MCK – Get Rating) by 41.6% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 17,413 shares of the company's stock after purchasing an additional 5,117 shares during the period. McKesson accounts for approximately 1.7% of Dorsey Wright & Associates' holdings, making the stock its 7th biggest position. Dorsey Wright & Associates' holdings in McKesson were worth $5,680,000 at the end of the most recent quarter.
根據Dorsey Wright&Associates最近向美國證券交易委員會提交的13F文件,該公司在第二季度將其在McKesson Co.(紐約證券交易所代碼:MCK-GET Rating)的股票頭寸提高了41.6%。在此期間,該公司又購買了5,117股,持有該公司17,413股股票。McKesson約佔Dorsey Wright&Associates持股的1.7%,使其成為其第7大持倉。截至最近一個季度末,Dorsey Wright&Associates在McKesson持有的股份價值5,68萬美元。
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. BlackRock Inc. boosted its stake in McKesson by 2.1% during the 4th quarter. BlackRock Inc. now owns 13,171,252 shares of the company's stock valued at $3,273,976,000 after purchasing an additional 269,506 shares during the period. JPMorgan Chase & Co. lifted its stake in shares of McKesson by 4.1% in the 1st quarter. JPMorgan Chase & Co. now owns 5,965,095 shares of the company's stock worth $1,826,096,000 after acquiring an additional 235,874 shares during the period. Bank of New York Mellon Corp lifted its stake in shares of McKesson by 0.3% in the 1st quarter. Bank of New York Mellon Corp now owns 1,976,639 shares of the company's stock worth $605,109,000 after acquiring an additional 5,265 shares during the period. Norges Bank acquired a new stake in shares of McKesson in the 4th quarter worth approximately $386,729,000. Finally, Acadian Asset Management LLC lifted its stake in shares of McKesson by 360.8% in the 1st quarter. Acadian Asset Management LLC now owns 1,077,083 shares of the company's stock worth $329,689,000 after acquiring an additional 843,348 shares during the period. 86.43% of the stock is owned by institutional investors and hedge funds.
其他一些對衝基金和其他機構投資者最近也買賣了該公司的股票。貝萊德股份有限公司在第四季度增持了麥凱森2.1%的股份。貝萊德股份有限公司在此期間增持了269,506股,目前持有該公司13,171,252股股票,價值3,273,976,000美元。摩根大通在第一季度增持了4.1%的McKesson股票。摩根大通在此期間增持了235,874股,目前持有5,965,095股該公司股票,價值1,826,096,000美元。紐約梅隆銀行(Bank Of New York Mellon Corp)第一季度增持了0.3%的McKesson股票。紐約梅隆銀行(Bank Of New York Mellon Corp)目前持有1,976,639股該公司股票,價值605,109,000美元,在此期間又購買了5,265股。挪威銀行在第四季度收購了McKesson公司價值約386,729,000美元的新股份。最後,Acadian Asset Management LLC在第一季度增持了360.8%的McKesson股票。Acadian Asset Management LLC在此期間額外收購了843,348股,目前擁有1,077,083股該公司股票,價值329,689,000美元。86.43%的股票由機構投資者和對衝基金持有。
McKesson Price Performance
麥凱森性價比
McKesson stock traded down $7.53 during trading hours on Thursday, hitting $341.41. The company had a trading volume of 17,551 shares, compared to its average volume of 1,031,360. The firm has a market capitalization of $49.07 billion, a P/E ratio of 35.97, a price-to-earnings-growth ratio of 1.39 and a beta of 0.59. The firm's fifty day moving average is $353.06 and its 200-day moving average is $330.05. McKesson Co. has a fifty-two week low of $193.89 and a fifty-two week high of $375.23.
在週四的交易時段,麥克森的股價下跌了7.53美元,觸及341.41美元。該公司成交量為17,551股,而其平均成交量為1,031,360股。該公司的市值為490.7億美元,市盈率為35.97倍,市盈率為1.39倍,貝塔係數為0.59。該公司的50日移動均線切入位在353.06美元,200日移動均線切入位在330.05美元。McKesson Co.股價跌至52周低點193.89美元,52周高點375.23美元。
McKesson Increases Dividend
麥凱森增加股息
The firm also recently announced a quarterly dividend, which will be paid on Monday, October 3rd. Shareholders of record on Thursday, September 1st will be given a $0.54 dividend. This represents a $2.16 annualized dividend and a yield of 0.63%. This is an increase from McKesson's previous quarterly dividend of $0.47. The ex-dividend date is Wednesday, August 31st. McKesson's payout ratio is currently 22.83%.
該公司最近還宣佈了季度股息,將於10月3日星期一支付。9月1日星期四登記在冊的股東將獲得0.54美元的股息。這意味着年化股息為2.16美元,收益率為0.63%。這比McKesson之前季度0.47美元的股息有所增加。除息日為8月31日(星期三)。McKesson的派息率目前為22.83%。
Wall Street Analysts Forecast Growth
華爾街分析師預測經濟增長
A number of analysts have recently weighed in on the stock. Credit Suisse Group upped their price target on shares of McKesson from $377.00 to $385.00 and gave the stock an "outperform" rating in a research note on Monday, August 8th. Deutsche Bank Aktiengesellschaft upped their price target on shares of McKesson from $378.00 to $409.00 in a research note on Monday, August 8th. Mizuho boosted their target price on shares of McKesson from $331.00 to $345.00 and gave the stock a "neutral" rating in a report on Thursday, August 4th. Argus boosted their target price on shares of McKesson from $370.00 to $430.00 and gave the stock a "buy" rating in a report on Monday, September 12th. Finally, UBS Group boosted their target price on shares of McKesson from $380.00 to $400.00 and gave the stock a "buy" rating in a report on Thursday, August 4th. One research analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Buy" and a consensus target price of $352.46.
一些分析師最近對該股進行了加碼。瑞士信貸集團將麥凱森股票的目標價從377.00美元上調至385.00美元,並在8月8號週一的一份研究報告中給出了該股“跑贏大盤”的評級。Deutsche Bank Aktiengesellschaft在8月8日週一的一份研究報告中將麥克森的股票目標價從378.00美元上調至409.00美元。瑞穗在8月4日週四的一份報告中將麥克森股票的目標價從331.00美元上調至345.00美元,並給予該股“中性”評級。Argus將McKesson股票的目標價從370.00美元上調至430.00美元,並在9月12日週一的一份報告中給予該股“買入”評級。最後,瑞銀集團將麥凱森股票的目標價從380.00美元上調至400.00美元,並在8月4日週四的一份報告中給予該股“買入”評級。一位研究分析師對該股的評級為持有,11位分析師給出了買入評級,一位分析師給出了該公司股票的強力買入評級。根據MarketBeat的數據,該公司目前的共識評級為買入,共識目標價為352.46美元。
Insiders Place Their Bets
內部人士下注
In other McKesson news, EVP Lori A. Schechter sold 7,500 shares of the business's stock in a transaction that occurred on Thursday, September 15th. The shares were sold at an average price of $343.94, for a total value of $2,579,550.00. Following the completion of the sale, the executive vice president now directly owns 11,678 shares of the company's stock, valued at $4,016,531.32. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other McKesson news, EVP Lori A. Schechter sold 7,500 shares of the business's stock in a transaction that occurred on Thursday, September 15th. The shares were sold at an average price of $343.94, for a total value of $2,579,550.00. Following the completion of the sale, the executive vice president now directly owns 11,678 shares of the company's stock, valued at $4,016,531.32. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Thomas L. Rodgers sold 1,300 shares of the business's stock in a transaction that occurred on Thursday, September 8th. The stock was sold at an average price of $367.21, for a total transaction of $477,373.00. Following the completion of the sale, the executive vice president now directly owns 2,544 shares of the company's stock, valued at $934,182.24. The disclosure for this sale can be found here. Insiders own 0.21% of the company's stock.
在McKesson的其他新聞,執行副總裁洛裏·A·謝克特在9月15日星期四的一筆交易中出售了7500股該公司的股票。這些股票的平均價格為343.94美元,總價值為2579,550.00美元。出售完成後,執行副總裁總裁現在直接持有該公司11678股股票,價值4016531.32美元。這筆交易是在提交給美國證券交易委員會的一份法律文件中披露的,該文件可通過此超鏈接。在McKesson的其他新聞,執行副總裁洛裏·A·謝克特在9月15日星期四的一筆交易中出售了7500股該公司的股票。這些股票的平均價格為343.94美元,總價值為2579,550.00美元。出售完成後,執行副總裁總裁現在直接持有該公司11678股股票,價值4016531.32美元。這筆交易是在提交給美國證券交易委員會的一份法律文件中披露的,該文件可通過此超鏈接。此外,執行副總裁託馬斯·L·羅傑斯在9月8日星期四的一次交易中出售了1300股該公司的股票。該股以367.21美元的平均價格出售,總成交金額為477,373.00美元。出售完成後,執行副總裁總裁現在直接持有該公司2544股股票,價值934,182.24美元。關於這次銷售的披露可以找到這裏。內部人士持有該公司0.21%的股份。
McKesson Profile
麥凱森檔案
(Get Rating)
(獲取評級)
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products.
McKesson公司在美國和國際上提供醫療服務。它通過四個部門運作:美國製藥、國際、醫療-外科解決方案和處方技術解決方案(RxTS)。美國製藥部門分銷品牌、仿製藥、特效藥、生物相似藥和非處方藥以及其他與醫療保健相關的產品。
Featured Articles
專題文章
- Get a free copy of the StockNews.com research report on McKesson (MCK)
- This Small-Cap Healthcare Name Is Outperforming Its Index
- What Cintas Can Teach Investors About This Bear Market?
- 2 Casino Stocks Worth Taking a Look At
- Blackberry Stock Declines As Results Come In Lukewarm Once Again
- A Trio of Q3 Winners With Room to Run
- 免費獲取StockNews.com關於McKesson(MCK)的研究報告
- 這家小盤股醫療保健公司的表現好於其指數
- 關於這個熊市,Cintas能教給投資者什麼?
- 值得一看的2只賭場股票
- 黑莓股價下跌,業績再次不温不火
- 第三季度贏家三人組還有運行的空間
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.
接受McKesson Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對McKesson和相關公司的最新新聞和分析師評級的每日簡要摘要。